The effect between metabolic syndrome and life expectancy after cancer diagnosis: Catalan cohort study

The effect between metabolic syndrome and life expectancy after cancer diagnosis: Catalan cohort study

Abstract This study examines remaining life expectancy (RLE) after a cancer diagnosis, focusing on age, sex, cancer type, and metabolic syndrome (MS) components, using data from the SIDIAP database in Catalonia (2006–2017). RLE was analyzed for 13 cancer types, stratified by sex and MS components. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomàs López-Jiménez, Oleguer Plana-Ripoll, Talita Duarte-Salles, Anna Palomar-Cros, Diana Puente
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Public Health
Subjects:
Metabolic syndrome
Cancer
Remaining life expectancy
Survival
Online Access:https://doi.org/10.1186/s12889-025-21437-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items